Free Trial

Avantor (NYSE:AVTR) Issues FY 2026 Earnings Guidance

Avantor logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • FY 2026 EPS guidance of 0.770–0.830 (consensus 0.790) was issued, while the company did not provide any revenue guidance.
  • Shares fell about 2.4% to $7.81 on the news; the stock trades near its 52‑week low, analysts’ consensus rating is “Hold” with a $11.80 target, and several firms have recently downgraded the name.
  • Insiders bought shares recently — Directors Gregory T. Lucier and Gregory L. Summe acquired 50,000 and 100,000 shares respectively, and insiders purchased 275,000 shares (~$2.4M) in the last quarter.
  • MarketBeat previews the top five stocks to own by June 1st.

Avantor (NYSE:AVTR - Get Free Report) updated its FY 2026 earnings guidance on Thursday. The company provided EPS guidance of 0.770-0.830 for the period, compared to the consensus EPS estimate of 0.790. The company issued revenue guidance of -.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on AVTR. Jefferies Financial Group reissued an "underperform" rating and set a $8.00 target price on shares of Avantor in a research note on Thursday, February 12th. Zacks Research lowered Avantor from a "hold" rating to a "strong sell" rating in a research note on Friday, February 13th. Morgan Stanley set a $10.00 target price on Avantor in a research note on Friday, February 13th. Bank of America lowered Avantor from a "buy" rating to a "neutral" rating and set a $13.00 target price on the stock. in a research note on Monday, December 15th. Finally, Barclays reissued an "underweight" rating and set a $8.50 target price on shares of Avantor in a research note on Friday, March 6th. Three investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $11.80.

View Our Latest Analysis on Avantor

Avantor Stock Down 2.4%

NYSE AVTR traded down $0.20 during trading hours on Thursday, hitting $7.81. 2,313,476 shares of the company were exchanged, compared to its average volume of 11,245,591. The company has a 50 day moving average of $8.81 and a two-hundred day moving average of $11.02. The company has a quick ratio of 1.18, a current ratio of 1.78 and a debt-to-equity ratio of 0.70. Avantor has a 52-week low of $7.26 and a 52-week high of $16.17. The firm has a market cap of $5.32 billion, a price-to-earnings ratio of -10.01, a PEG ratio of 3.10 and a beta of 1.00.

Avantor (NYSE:AVTR - Get Free Report) last issued its quarterly earnings results on Wednesday, February 11th. The company reported $0.22 earnings per share for the quarter, topping the consensus estimate of $0.21 by $0.01. Avantor had a positive return on equity of 10.45% and a negative net margin of 8.09%.The company had revenue of $1.66 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the prior year, the business earned $0.27 EPS. Avantor's revenue was down 1.4% on a year-over-year basis. Avantor has set its FY 2026 guidance at 0.770-0.830 EPS. Equities research analysts anticipate that Avantor will post 1.06 earnings per share for the current year.

Insiders Place Their Bets

In other Avantor news, Director Gregory T. Lucier acquired 50,000 shares of the company's stock in a transaction dated Thursday, February 19th. The shares were acquired at an average price of $9.16 per share, for a total transaction of $458,000.00. Following the acquisition, the director owned 50,000 shares in the company, valued at $458,000. The trade was a ∞ increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Gregory L. Summe acquired 100,000 shares of the company's stock in a transaction dated Thursday, February 12th. The stock was acquired at an average price of $9.40 per share, for a total transaction of $940,000.00. Following the acquisition, the director owned 400,000 shares in the company, valued at approximately $3,760,000. The trade was a 33.33% increase in their position. The SEC filing for this purchase provides additional information. Insiders have purchased a total of 275,000 shares of company stock worth $2,399,250 in the last quarter. 1.20% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. EverSource Wealth Advisors LLC increased its holdings in shares of Avantor by 119.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company's stock valued at $29,000 after acquiring an additional 1,189 shares during the last quarter. Strategic Wealth Investment Group LLC purchased a new position in shares of Avantor in the 2nd quarter valued at about $32,000. Osaic Holdings Inc. increased its holdings in shares of Avantor by 60.9% in the 2nd quarter. Osaic Holdings Inc. now owns 2,810 shares of the company's stock valued at $38,000 after acquiring an additional 1,064 shares during the last quarter. Los Angeles Capital Management LLC purchased a new position in shares of Avantor in the 4th quarter valued at about $32,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of Avantor by 28.1% in the 3rd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 4,123 shares of the company's stock valued at $49,000 after acquiring an additional 905 shares during the last quarter. Hedge funds and other institutional investors own 95.08% of the company's stock.

Avantor Company Profile

(Get Free Report)

Avantor, Inc NYSE: AVTR is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor's offerings are organized across two primary segments.

Recommended Stories

Earnings History and Estimates for Avantor (NYSE:AVTR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Avantor Right Now?

Before you consider Avantor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avantor wasn't on the list.

While Avantor currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines